Pick Hot Stocks, That Will Reduce Investor Risk ( GM, TGT, HEB, ARQL )

Los Angelas, CA -- (SBWIRE) -- 10/17/2012 -- General Motors Co (NYSE:GM) reported EPS of 2.807. For the Current Fiscal year, the company is expected to report EPS of 3.12. For the Next Quarter and Next Year, the company is expected to report EPS of 0.69 and 3.88 respectively. At Current Market Price, GM is in distance of +5.57% from its 50-day Moving Average price of $23.4826 and +12.47% from its 200-day Moving Average price of $22.0416. General Motors Co. (GM) said it will begin production of the Cadillac ELR, a two-door, plug-in hybrid that uses Chevrolet Volt-like technology, late next year. The company will invest $35 million in its Detroit- Hamtramck Assembly plant to build the new model, Mark Reuss, president of GM North America, said in a speech in Detroit. The factory already builds the Volt. Cadillac is GM’s luxury brand.

CAN GM Touch $ 27.00 In Short Term : FIND OUT HERE

Target Corporatio (NYSE:TGT) is very active today and traded between $62.11 - 62.99 with total traded volume of 3846437 shares. At a current price of 62.90, TGT is +1.09 - +1.76% from the previous close of $61.81. Moreover, At Current Market Price, TGT is in distance of -1.50% from its 50-day Moving Average price of $63.8574 and +4.56% from its 200-day Moving Average price of $60.1545. Target (NYSE: TGT) entered the price war by announcing that they would also match prices on select online retailers. Target's CEO Gregg Steinhafel told reporters at a conference Tuesday that the retailers include Amazon.com, Walmart.com, Bestbuy.com, Toysrus.com and babiesrus.com.

Sign Up Here To Get Free Analysis Report On TGT

Hemispherx BioPha (AMEX:HEB) is +0.01 - +1.35% from the previous close of $0.74. It traded between $0.68 - 0.80 with total traded volume of 2553468 shares. Keep a close eye on HEB, as the stock has been showing unusual moves over the past weeks. At Current market price, HEB has recovered +341.18% from its 52-week Low of 0.17 and has Pulled back -31.82% from its 52-week high of 1.10. Hemispherx BioPharma, Inc(NYSEAMEX:HEB) shares increased 1.35% to $0.750. The company, on Oct. 1, announced that the Company has filed with ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, an amended NDA for the use of its natural-source Alferon N Injection® (under the brand name “Naturaferon”) in patients with chronic hepatitis C who have become refractory to recombinant interferon as a result of the appearance of neutralizing antibodies (NABs) against recombinant interferon.

Don’t forget To Apply For Trend Analysis: CHECK HERE

ArQule, Inc. (NGM:ARQL) is +0.13 - +4.91% from the previous close of $2.65. It traded between $2.73 - 2.92 with total traded volume of 2106460 shares. Keep a close eye on ARQL, as the stock has been showing unusual moves over the past weeks. At Current market price, ARQL has recovered +40.40% from its 52-week Low of 1.98 and has Pulled back -66.59% from its 52-week high of 8.32. ArQule, Inc.(NASDAQ:ARQL) stock increased 4.91% to $2.83 following news that the FDA has agreed to a Special Protocol Assessment for the company’s planned Phase III tivantinib trial. ArQule is designing a study of its lead candidate as a second-line Hepatocellular Carcinoma (HCC) treatment. This is the drug’s second Phase III trial, following the discontinuation of a Phase III study for Non Small-Cell Lung Cancer (NSCLC) early this month.

How Should Investors React to ARQL Now? Find Out Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com